Monday, 7 September 2020

MCQ-88


 


Answer: a) Rituximab

Rituximab destroys both normal and malignant B cells that have CD20 on their surfaces; it is used in diseases where there are too many B cells, overactive or dysfunctional B cells.


No comments:

Post a Comment